Haematopoietic stem cell transplant (HSCT) recipients have deficiencies in their adaptive
immunity against vaccine preventable diseases. National and International guidance …

Reproductive late effects after hematopoietic stem cell transplant can have a significant
impact on cancer survivors' quality of life. Potential late effects include gonadal insufficiency …

ASCO Guidelines provide recommendations with comprehensive review and analyses of
the relevant literature for each recommendation, following the guideline development …

Objectives To assess the humoral immune response to the BNT162b2 vaccine after
allogeneic haematopoietic cell transplantation (HCT). Methods This is a prospective cohort …

Background Young survivors of cancer are at increased risk for cancers that are related to
human papillomavirus (HPV), primarily caused by oncogenic HPV types 16 and 18. We …

Chronic graft‐versus‐host disease (cGVHD) is an important systemic complication of
allogeneic haematopoietic stem cell transplantation with heterogeneous, multi‐organ …

To ensure continued impact on the prevention of HPV-associated disease and subsequent
cancer, it is crucial to address gaps in vaccine uptake. A strong recommendation for all …

Pediatric, adolescent and young adult patients undergoing cancer treatment and/or
hematopoietic stem cell transplant are at increased risk for developing a secondary human …

ABSTRACT GATA2 deficiency is a bone marrow failure syndrome effectively treated with
hematopoietic cell transplantation (HCT), which also addresses the predisposition to many …

Survivors of childhood cancer and other immunocompromised children are at high risk for
the development of secondary human papillomavirus (HPV)–associated cancers. In this …